Physician profile
Vida Khaliki
NPI 1619526373
$896.51
in general payments reported to CMS, 2019-2025
18 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.72 · 2022: $15.31 · 2023: $160 · 2024: $138 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $223.41 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Exact Sciences Corporation | $152.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Alk-Abello, INC | $98.86 | 2025 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $93.42 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $56.59 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Otsuka America Pharmaceutical, INC. | $52.79 | 2025 | Rexulti |
| Alkermes, INC. | $34.75 | 2025 | Vivitrol |
| Hologic Sales and Service, LLC | $20.38 | 2025 | Aptima |
| Abbvie INC. | $20.22 | 2021 | |
| Indivior INC. | $19.51 | 2024 | Sublocade |
| Sanofi Pasteur INC. | $18.29 | 2025 | |
| Glaxosmithkline, LLC. | $17.07 | 2021 | |
| Cranial Technologies, INC | $15.54 | 2025 | Doc Band |
| Biohaven Pharmaceuticals, INC. | $15.43 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.31 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.62 | 2023 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $14.21 | 2023 | Breztri |
| Lilly USA, LLC | $14.00 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vida Khaliki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.